2 American companies expect to apply for emergency approval for their Covid-19 vaccines by late Nov, welcome news as the US crossed 8 million confirmed cases. Pfizer said Friday it hopes to move ahead with its vaccine after safety data is available in the third week of November, weeks after the November 3 presidential election.
